Sign in
4

Changes in Ownership

Ernexa Therapeutics Inc. Filed Acc 0001019687-10-001063

CEO acquired 328,125 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bateman Terry Allan · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2010-03-19 Exercise or conversion : show line 1 in the form +328,125 $0.17 $55,781 503,958 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2010-03-19 Exercise or conversion : show line 2 in the form Employee Stock Option (Right to Buy) +328,125 1,276,042 D
Loading xslF345X03/edgar.xml…